A wearable cybernetic leg significantly improved the gait and ability to perform walking exercises of people with neuromuscular disorders, such…
Articles by Forest Ray PhD
Children with spinal muscular atrophy (SMA) who started taking Spinraza (nusinsersen) before symptoms appeared retained their ability to…
Meaningful further improvements in motor skills were evident with apitegromab treatment in later-onset spinal muscular atrophy (SMA) patients on maintenance…
Evrysdi (risdiplam) continues to be linked to motor function improvements in a broad range of people with spinal…
Evrysdi (risdiplam) has been approved by Health Canada for the at-home treatment of spinal muscular atrophy (SMA) in…
The United States Patent and Trademark Office has granted Scholar Rock a patent for apitegromab, with add-on and…
PTC Therapeutics and the Spinal Muscle Atrophy (SMA) Association will collaborate in funding research into regenerative medicine, and into…
Assistive equipment is vital to enhancing function, fun, and social participation in children with severe disabilities such as spinal…
Patient advocacy groups, a university, and pharmaceutical companies are among the 12 new partners of the European Alliance for Newborn…
The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…